Latest Updates

The Nagpur facility manufactures oral solid products

New results from a large pilot trial run at the University’s Warwick Medical School called ‘select-d’ suggest that a daily tablet…

Board of Directors recommends a dividend at the rate of Rs 75 per equity share for the 12 months period ended March 31, 2018

Paleja is a graduate from Bombay University and holds a Cost Accountants degree from the Institute of Cost Accountants of India

For the 12 months to March 2018, Temovate cream achieved annual sales of approximately $118 million

The drug will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad

Corcal Bone and Beauty is available in packs of 10 mini-tablets

The funds will be utlilised for clinical trials of pipeline molecules and securing IP for technologies for novel biological…

GBR 830 is a first-in-class, investigational, anti-OX40 monoclonal antibody for treatment of moderate-to-severe atopic dermatitis

The event will discuss on how pharma manufacturers should efficiently implement excellence initiatives

Signs deal for exclusive marketing and distribution of the only US FDA approved inhaled insulin

To treat hypertension, heart failure (NYHA class II – IV) and reduces cardiovascular mortality in clinically stable patients

For the treatment of platinum-sensitive relapsed ovarian cancer

Hospital business of Apotex will not form part of the merged entity and will be retained by Apotex

Products are being developed for cognitive disorders with high unmet medical need and with huge market potential globally

Etanercept (YLB113) is indicated for moderate to severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis

It is used for the treatment of schizophrenia and bipolar disease

CDSCO announces one year extension of WHO-GMP certifications

It will be the largest overseas acquisition by a Japanese company

After remaining in the negative territory for the first five months of the financial year 2017-18, pharma exports have picked up…